These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies on the adrenocortical hormone therapy in idiopathic nephrotic syndrome in children. Maki S; Iida H; Yoshida N Med J Osaka Univ; 1972 Mar; 22(4):259-300. PubMed ID: 4346365 [No Abstract] [Full Text] [Related]
24. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases]. Frank A Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890 [No Abstract] [Full Text] [Related]
25. Adrenal failure complicating status asthmaticus in steroid-treated patients. el-Shaboury AH Br Med J; 1966 Dec; 2(5528):1478-81. PubMed ID: 4288940 [No Abstract] [Full Text] [Related]
26. [Synthetic depot-ACTH, plasmacortisol levels, and asthmatic syndrome (author's transl)]. Illig H; Giesen HK Med Klin; 1975 Feb; 70(9):377-9. PubMed ID: 164616 [TBL] [Abstract][Full Text] [Related]
28. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients. Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190 [No Abstract] [Full Text] [Related]
29. Long-term ACTH treatment: an investigation. Sadow J; Penn R Proc R Soc Med; 1972 Sep; 65(9):788-9. PubMed ID: 4343591 [No Abstract] [Full Text] [Related]
30. [Diagnostic and therapeutic use of synthetic beta 1-24 corticotropin (30'920-BA Synacthen Ciba)]. Horký K; Küchel O Vnitr Lek; 1968 Apr; 14(4):370-9. PubMed ID: 4298653 [No Abstract] [Full Text] [Related]
31. [Errors and risks in corticoid therapy of bronchial asthma]. Popescu C Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):71-8. PubMed ID: 195327 [No Abstract] [Full Text] [Related]
32. A controlled transfer from oral corticosteroids to corticotrophin in bronchial asthma. Cook MG; Donovan B Br J Clin Pract; 1971 Sep; 25(9):407-12. PubMed ID: 4329645 [No Abstract] [Full Text] [Related]
33. [Adrenocorticotropic action of synthetic polypeptides following suppression of endogenous secretion of ACTH]. Jenny M; Mach RS; Muller AF; Boissonnas RA; Guttmann S; Pless J; Doepfner W Helv Med Acta Suppl; 1966 May; 46():166. PubMed ID: 4329277 [No Abstract] [Full Text] [Related]
34. [Hypophysoadrenal effects of prolonged corticotherapy in small doses in asthmatic patients]. Magnenat G; Cruchaud S; Ruedi B Schweiz Med Wochenschr; 1972 Jun; 102(23):804-9. PubMed ID: 4338343 [No Abstract] [Full Text] [Related]
35. [Indications, possibilities and limits of corticostimulation in current practice]. Codaccioni JL; Boyer J Rev Prat; 1972 Nov; 22(30):Suppl:84-6. PubMed ID: 4347614 [No Abstract] [Full Text] [Related]
36. [Results of nephrotic syndrome therapy in children]. Halikowski B; Rybakowa M; Kucharska K; Kostecka J Pediatr Pol; 1966 Jun; 41(6):655-60. PubMed ID: 4290268 [No Abstract] [Full Text] [Related]
37. [Effect of a tetracosactide with depot action in the asthmatic syndrome]. Illig H Med Klin; 1970 May; 65(20):985-7. PubMed ID: 4325139 [No Abstract] [Full Text] [Related]
39. Adrenocorticotropic hormone: An expansion of our current understanding of the treatment for nephrotic syndrome. Hu D; Li J; Zhuang Y; Mao X Steroids; 2021 Dec; 176():108930. PubMed ID: 34648797 [TBL] [Abstract][Full Text] [Related]